DEMO ABEE: “Φέρνουμε το Αύριο, Σήμερα” Η εταιρεία ανακοίνωσε το επενδυτικό πλάνο 2021-2027, αξίας 356 εκατ. ευρώ.
Σήμερα Τρίτη, 9 Νοεμβρίου 2021, παρουσιάστηκε από τον Διευθύνοντα Σύμβουλο της βιομηχανίας φαρμάκων κ. Δημήτρη Δέμο, το πολυδιάστατο πακέτο…
DEMO SA: “We Bring the Future into the Present” The company announced its 2021-2027 investment plan, worth EUR 356 million.
On Tuesday, November 9, 2021, the CEO of the pharmaceutical industry, Mr. Dimitris Demos, presented the company’s multidimensional investment package…
Positive messages from the use of Dexamethasone for coping with Covid-19. In 2021, DEMO SA shall launch a Dexamethasone formulation in Greece.
The DEMO Pharmaceutical Industry with 4 manufacturing units located in Kryoneri - Attica, shall be launching within the next few months, the…
Event for the New Year’s cake organized by DEMO ABEE Turnover increase by 16 million euros in comparison to 2018 New Investment Plan of the company for the following 5 years
With our wishes for a creative year, the Pharmaceutical industry DEMO ΑΒΕΕ welcomed 2020 in an event for the New Year’s Cake, which took place on…
DEMO SA wins Gold at the Manufacturing Excellence Awards 2019
DEMO SA Pharmaceutical Industry received the Gold Award for Manufacturing Excellence in the Pharmaceutical & Cosmetics Category at the Manufacturing…
Event of cutting the New Year’s cake organized by DEMO S.A. Pharmaceutical Industry The company’s new Investment Plan for 2019-2022 of a total amount of 30 million Euros
DEMO S.A. Pharmaceutical Industry welcomed 2019, expressing wishes for a creative new year at the event organized for cutting the New Year’s cake.…
DEMO S.A. Pharmaceutical Industry Two Golden Awards in the DEVELOPMENT section at the “Healthcare Business Awards 2018”
DEMO S.A. Pharmaceutical Industry stood out with two Golden Awards in the category for pharmaceutical companies during the “Healthcare Business…
Cutting the new year’ cake at DEMO S.A.
The pharmaceutical industry DEMO S.A. welcomed 2018 with wishes for a creative new year, at the event for the cutting of the New Year’s traditional…
DEMO SA awarded two Golden Awards at the “Healthcare Business Awards 2017”
The pharmaceutical industry Demo S.A. was honoured with two Golden Awards in the pharmaceutical companies category at the ‘Healthcare Business Awards…
Positive messages at the New Year’s Corporate event Investment and export development: the strategic axes Fourth Plant at Kryoneri
The pharmaceutical manufacturer Demo SA wished everyone a productive year at their New Year’s Corporate event. The event, held on Friday, January 27,…
Another distinction for DEMO’s business course
The pharmaceutical company DEMO acquired an important distinction for its business course and its developmental approach, at the Annual Convention of…
DEMO Employees voluntarily participated in Blood Donation 10 years Blood Bank
For the 10th consecutive year, on Friday 8th April, the pharmaceutical industry DEMO organized the Voluntary Blood Donation Day for its employees.…
2015 | a year of success for DEMO S.A.
DEMO SA pharmaceutical industry welcomed 2016 with wishes for a productive new year. The event for the celebration of the New Year, which took place…
Christmas celebration for the children of the company’s employees and message of support to the refugees by sending them relief items
Christmas spirit came to life at the DEMO’s premises in Kryoneri, Attica, where the Company’s Christmas Celebration took place with guests the…
DEMO’s Awards for its business performance
The successful business course of the Greek pharmaceutical company DEMO SA stands out as well as it is acknowledged. The company received two major…
DEMO S.A. sponsors the “Pablo Picasso-Jean Cocteau, The Modernist Innovators” Exhibition
DEMO SA , which supports our country’s culture and young people’s contact with the global works of art, is the key sponsor of the Exhibition “Pablo…
DEMO SA’s family celebrates its 50th anniversary
It was fifty years ago when Stavros Demos opened a pharmacy, which has evolved into the biggest pharmaceutical company in the domestic hospital…
DEMO S.A is certified member of TRACE
DEMO S.A is certified member of the internationally recognized organization TRACE, which works together with companies to promote and ensure…
Teicoplanin DCP registration proceeds as planned
DEMO Pharmaceutical Industry S.A. today announced the pan-european registration of its Teicoplanin injection product (Talinac) is proceeding as…
DEMO S.A. announces the inauguration of its new dedicated penem facility
DEMO S.A. today announced the inauguration of its brand new production facility for carbapenems. The new facility has been designed in accordance…
Meropenem DCP registration proceeds as planned
DEMO Pharmaceutical Industry S.A. today was informed by the UK regulatory authorities that its pan-european registration of its Meropenem injection…